| Financial Year |
March 31 2023 |
| Monetary Funds |
284,640,724.75 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
5,080,000.00 |
| Accounts Receivable |
259,833,376.12 |
| Advances to Suppliers |
32,534,559.74 |
| Other Receivables |
14,719,921.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,794,338.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
171,120,537.44 |
| Total Current Assets |
1,907,674,757.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,747,319.77 |
| Investment Properties |
-- |
| Fixed Assetes |
128,375,730.37 |
| Under-construction Projects |
265,186.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
895,817.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
212,495.23 |
| Deferred Income Tax Assets |
49,472,527.14 |
| Other Non-Current Assets |
61,970,619.92 |
| Sub-Total of Non-Current Assets |
257,282,728.16 |
| Total Assets |
2,164,957,485.18 |
| Short-Term Loans |
48,986,415.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,733,198.55 |
| Accounts Payable |
180,135,712.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,473,132.86 |
| Taxes Payable |
5,289,653.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,542,834.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,044,416.60 |
| Other Current Liabilities |
131,934,092.25 |
| Sub-Total of Current Liabilities |
431,145,478.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,239,282.60 |
| Total Liabilities |
434,384,760.78 |
| Paid-In Capital(Or Share Stock) |
99,251,600.00 |
| Capital Surplus |
1,226,311,145.75 |
| Surplus Reserve |
44,400,109.49 |
| LESS:Treasury Stock |
48,006,373.20 |
| Undistributed Profits |
390,128,389.71 |
| Minority Stockholder's Interest |
-2,307,040.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,732,879,764.43 |
| Owner's Equity（Stockholder's Equity） |
1,730,572,724.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,164,957,485.18 |
